This article discusses the risk and opportunities of six major constituents of PJP ETF: Pfizer, Amgen, Gilead, AbbVie, BMY, ...

Lower interest rates boost biotech investments by increasing risk appetite, benefiting pre-commercial biotechs. Read more on how these companies may perform in 2025.

The result: The United Nations says that, at best, it will be able to raise enough money to help about 60% of the 307 million people it predicts will need humanitarian aid next year. That means at ...

Novo Nordisk and Eli Lilly face soaring demand--and stiff competition--as obesity drug market transforms healthcare and ...

In lab studies, the orally active drug has been shown to degrade the VAV1 ... a $2 billion agreement between Orionis and Roche, and MSD/Merck & Co's $2.55 billion deal with Proxygen.

According to the NYPD, a 58-year-old cab driver suffered a medical episode when he drove onto the sidewalk at West 34th Street and Sixth Avenue. A man accused of attempting to assassinate ...